Clinical Trial Update: Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for Depocyt in adults with acute lymphocytic leukemia or aggressive lymphoma with CNS relapse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Leukemia

Drugs mentioned

• DepoCyt (liposomal cytarabine)

Snippet

Sponsor: Goethe University | Conditions: Adult Acute Lymphocytic Leukemia | Phase 2, Phase 3 | Status: COMPLETED